Kyle Mikson
Stock Analyst at Canaccord Genuity
(1.15)
# 3,820
Out of 4,876 analysts
89
Total ratings
32.43%
Success rate
-13.81%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Hold | $87 → $99 | $94.79 | +4.44% | 11 | Jun 11, 2025 | |
| AKYA Akoya Biosciences | Maintains: Hold | $1.8 → $1.08 | $1.24 | -12.90% | 5 | May 19, 2025 | |
| GRAL GRAIL | Maintains: Buy | $32 → $43 | $48.39 | -11.14% | 2 | May 14, 2025 | |
| BDSX Biodesix | Maintains: Buy | $2.5 → $1.5 | $0.25 | +499.28% | 4 | May 14, 2025 | |
| XGN Exagen | Maintains: Buy | $7 → $8 | $6.99 | +14.53% | 3 | May 13, 2025 | |
| QTRX Quanterix | Maintains: Buy | $15 → $12 | $6.65 | +80.45% | 6 | May 13, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $18 → $15 | $11.73 | +27.88% | 8 | May 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $42 → $37 | $20.39 | +81.51% | 4 | May 6, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $65 | $50.86 | +27.80% | 7 | May 1, 2025 | |
| RGEN Repligen | Maintains: Hold | $170 → $150 | $123.56 | +21.40% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.29 | +132.56% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $195 | $167.96 | +16.10% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.17 | +156.41% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1.5 → $1 | $1.95 | -48.72% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $53.65 | +39.79% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.84 | +138.75% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.60 | +8,100.00% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $3.80 | +400.00% | 1 | Jan 29, 2021 |
Illumina
Jun 11, 2025
Maintains: Hold
Price Target: $87 → $99
Current: $94.79
Upside: +4.44%
Akoya Biosciences
May 19, 2025
Maintains: Hold
Price Target: $1.8 → $1.08
Current: $1.24
Upside: -12.90%
GRAIL
May 14, 2025
Maintains: Buy
Price Target: $32 → $43
Current: $48.39
Upside: -11.14%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.25
Upside: +499.28%
Exagen
May 13, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $6.99
Upside: +14.53%
Quanterix
May 13, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $6.65
Upside: +80.45%
10x Genomics
May 12, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $11.73
Upside: +27.88%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $42 → $37
Current: $20.39
Upside: +81.51%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $60 → $65
Current: $50.86
Upside: +27.80%
Repligen
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $123.56
Upside: +21.40%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.29
Upside: +132.56%
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $167.96
Upside: +16.10%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.17
Upside: +156.41%
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $1.95
Upside: -48.72%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $53.65
Upside: +39.79%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.84
Upside: +138.75%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.60
Upside: +8,100.00%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $3.80
Upside: +400.00%